Is hematopoietic stem cell transplantation a therapeutic option for mucolipidosis type II?

BACKGROUND: Mucolipidosis type II (MLII) is an ultra-rare lysosomal storage disorder caused by defective lysosomal enzyme trafficking. Clinical hallmarks are craniofacial dysmorphia, cardiorespiratory dysfunction, hepatosplenomegaly, skeletal deformities and neurocognitive retardation. Death usually...

Descripción completa

Detalles Bibliográficos
Autores principales: Ammer, Luise Sophie, Pohl, Sandra, Breyer, Sandra Rafaela, Aries, Charlotte, Denecke, Jonas, Perez, Anna, Petzoldt, Martin, Schrum, Johanna, Müller, Ingo, Muschol, Nicole Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815485/
https://www.ncbi.nlm.nih.gov/pubmed/33505859
http://dx.doi.org/10.1016/j.ymgmr.2020.100704

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815485/
https://www.ncbi.nlm.nih.gov/pubmed/33505859
http://dx.doi.org/10.1016/j.ymgmr.2020.100704

Ejemplares similares